EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomics-Driven Discovery of Plantariitin A, a New Lipopeptide in Burkholderia plantarii DSM9509

Xiuling Wang, Zhuo Zhang, Jun Fu, Ruijuan Li iD

Molecules · 2025

DOI: 10.3390/molecules30040868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Xiuling Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China. Hauptthemen laut MEDLINE: Burkholderia, Lipopeptides, Genomics. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Funding of this research was provided by the National Key R&D Program of China, the National Natural Science Foundation of China, the 111 Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A significant number of silent biosynthetic gene clusters (BGCs) within the Burkholderia genome remain uncharacterized, representing a valuable opportunity for the discovery of new natural products. In this research, the recombineering system ETh1h2e_yi23, which facilitates recombination in Burkholderia and was developed in our previous study, was used for mining the BGCs of B. plantarii DSM9509. By using this recombineering system, the constitutive promoter was precisely inserted into the genome, resulting in the activation of the silent pla BGC, which led to the production of a new lipopeptide named plantariitin A. A distinctive characteristic of this lipopeptide is the incorporation of a non-proteinogenic amino acid residue, i.e., amino-1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinepropanoic acid (ATDPP), which has not been identified in other natural products. A biological activity assay demonstrated that plantariitin A exhibits anti-inflammatory activity. This study further substantiates the notion that the in situ activation of silent BGCs is a crucial strategy for the discovery of new natural products within the genus Burkholderia. With the increasing availability of genomic data and the development of bioinformatics tools, Burkholderia is poised to emerge as a prominent source for the development of new lipopeptides.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BurkholderiaLipopeptidesGenomicsMultigene FamilyGenome, BacterialBiological ProductsAnti-Inflammatory Agents

Stichwörter der Autor:innen

Burkholderia plantariiin situ activationlipopeptidesrecombineering systemunusual amino acid

Substanzen

LipopeptidesBiological ProductsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.

ORCID-Profile: Ruijuan Li

Förderung

  • Funding of this research was provided by the National Key R&D Program of China
  • the National Natural Science Foundation of China
  • the 111 Project
  • the SKLMT Frontiers and Challenges Project
  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • 111 Project
  • Taishan Scholar Program of Shandong Province

Zitieren

APA

Wang, X., Zhang, Z., Fu, J., & Li, R. (2025). Genomics-Driven Discovery of Plantariitin A, a New Lipopeptide in Burkholderia plantarii DSM9509. Molecules. https://doi.org/10.3390/molecules30040868

Vancouver

Wang X, Zhang Z, Fu J, Li R. Genomics-Driven Discovery of Plantariitin A, a New Lipopeptide in Burkholderia plantarii DSM9509. Molecules. 2025. doi:10.3390/molecules30040868

BibTeX
@article{Wang2025,
  author = {Wang, Xiuling and Zhang, Zhuo and Fu, Jun and Li, Ruijuan},
  title = {Genomics-Driven Discovery of Plantariitin A, a New Lipopeptide in Burkholderia plantarii DSM9509},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30040868}
}
Kostenlos starten →